Arvinas (ARVN) Enterprise Value (2017 - 2026)
Arvinas (ARVN) recorded quarterly Enterprise Value of -$614.9 million in Q1 2026, up 10.29% quarter-over-quarter from -$685.4 million in Q4 2025, and up 35.57% on a YoY basis from -$453.6 million in Q1 2025.
Arvinas (ARVN) Enterprise Value (2017 - 2026) Analysis & Trends
Arvinas' Enterprise Value history runs 10 years deep, the most recent figure standing at -$614.9 million for Q1 2026.
- In Q1 2026, Enterprise Value rose 35.57% year-over-year to -$614.9 million; the TTM figure through Mar 2026 stood at -$614.9 million (up 35.57% YoY), while the FY2025 annual figure was -$685.4 million, up 34.06% from the prior year.
- Enterprise Value was -$614.9 million for Q1 2026 at Arvinas, up from -$685.4 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$66.8 million in Q1 2022 to a low of -$1.3 billion in Q4 2023.
- Historically, Enterprise Value has averaged -$552.2 million across 5 years, with a median of -$614.9 million in 2026.
- The sharpest annual moves came in 2022 and 2023: Enterprise Value soared 89.74% in 2022, then plunged 1352.76% in 2023.
- A 5-year view of Enterprise Value shows it stood at -$86.8 million in 2022, then slumped by 1352.76% to -$1.3 billion in 2023, then grew by 17.57% to -$1.0 billion in 2024, then soared by 34.06% to -$685.4 million in 2025, then increased by 10.29% to -$614.9 million in 2026.
- The last three Enterprise Value figures came in at -$614.9 million (Q1 2026), -$685.4 million (Q4 2025), and -$787.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Arvinas | 492.16 Mn | -122.74 Mn | - | -614.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -614.90 Mn |
| Dec 31, 2025 | -685.40 Mn |
| Sep 30, 2025 | -787.60 Mn |
| Jun 30, 2025 | -861.20 Mn |
| Mar 31, 2025 | -954.30 Mn |
| Dec 31, 2024 | -1.04 Bn |
| Sep 30, 2024 | -1.12 Bn |
| Jun 30, 2024 | -1.23 Bn |
| Mar 31, 2024 | -93.50 Mn |
| Dec 31, 2023 | -1.26 Bn |
| Sep 30, 2023 | -119.20 Mn |
| Jun 30, 2023 | -96.10 Mn |
| Mar 31, 2023 | -135.70 Mn |
| Dec 31, 2022 | -86.80 Mn |
| Sep 30, 2022 | -138.10 Mn |
| Jun 30, 2022 | -97.70 Mn |
| Mar 31, 2022 | -66.80 Mn |
| Dec 31, 2021 | -112.80 Mn |
| Sep 30, 2021 | -260.16 Mn |
| Jun 30, 2021 | -600.58 Mn |